Skip to main navigation Skip to search Skip to main content

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vasoocclusive Crises

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date02/2/22 → 01/1/26

Funding

  • Global Blood Therapeutics: $29,175.00